Biotest AG VZ Stock
Price
Target price
€26.80
€26.80
-0.740%
-
-0.740%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Biotest AG VZ Stock
Biotest AG VZ shows a slight decrease today, losing €0.000 (-0.740%) compared to yesterday.
Pros and Cons of Biotest AG VZ in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biotest AG VZ vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biotest AG VZ | -0.740% | 2.682% | 0.375% | -15.723% | -13.548% | -19.760% | 21.542% |
| MPH Health Care AG | 0.750% | -1.471% | -22.989% | 69.620% | 61.446% | -10.067% | -36.493% |
| Biotest AG ST | -0.470% | 2.913% | 2.415% | 0.474% | 0.000% | 26.190% | 89.286% |
| Rockwell Medical Inc. | 3.230% | -5.382% | -2.027% | -68.169% | -10.784% | -79.995% | -94.715% |
News
EQS-News: Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion
EQS-News: Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion
EQS-News: Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds'
EQS-News: Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds'
EQS-News: Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo
EQS-News: Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo